Nattokinase: Uses, Mechanism, Dosage, and Safety

Nattokinase is a fibrinolytic enzyme associated with natto, the traditional fermented soybean food. Most supplement claims focus on its proposed effects on fibrin breakdown and clotting pathways. That said, the supplement and the food are not interchangeable: natto is a whole food with a broader nutritional profile, while a capsule is a concentrated product built around a single bioactive component.¹²¹⁴¹⁵

People usually reach for nattokinase for circulation, blood pressure, clot-related support, and sometimes for lipids, inflammation, or plaque-related concerns. Those uses are understandable because the proposed mechanism sounds cardiovascular, but the clinical evidence is uneven. The strongest signals come from blood pressure studies and short-term biomarker changes, not from hard outcome trials showing fewer heart attacks or strokes.³⁴⁵⁶⁷

For blood pressure, the evidence is modestly favorable: a randomized trial found lower systolic and diastolic pressure with 2,000 FU capsules over 8 weeks, and a 2023 meta-analysis also found reductions versus placebo. Lipid findings are much less consistent. The meta-analysis did not find significant overall LDL-C, HDL-C, or triglyceride benefit, although some individual or combination-product studies reported improvement. Short studies also found changes in fibrinogen, factor VII, factor VIII, D-dimer, and fibrin/fibrinogen degradation products, which supports a biologic effect on clot-related pathways.^3456101617

Claims about plaque reversal or atherosclerosis improvement need extra caution. A large randomized trial using 2,000 FU/day for a median of 3 years did not significantly slow carotid intima-media thickness progression or carotid arterial stiffness, and it also found no significant blood pressure or laboratory effect in low-risk healthy people. Other plaque-related studies exist, but some are open-label, retrospective, or use combination supplements, so they cannot confidently show that nattokinase alone reverses plaque or calcification.^789101718

Human studies in the evidence here used doses around 2,000 FU/day and 4,000 FU/day, with some longer clinical work reporting 10,800 FU/day. Study durations ranged from a single dose to 8 weeks, 2 months, 90 days, 12 months, and about 3 years. That makes the overall picture useful for context, but it does not create a single standard dose. FU is the usual activity unit, and product potency, activity, and stability can vary, so label guidance matters.^35679102

The main safety concern is bleeding risk, especially for people taking aspirin, anticoagulants, or other antiplatelet drugs. A case report described cerebellar hemorrhage after nattokinase was taken with aspirin in a person with cerebral microbleeds, and a mechanistic paper supports caution with anticoagulant therapies. Because of that, people with bleeding disorders, recent stroke, upcoming surgery or procedures, pregnancy, breastfeeding, or uncontrolled hypertension should not treat nattokinase as a routine self-care supplement without medical review.¹²¹³⁶

Reasonably, nattokinase can be described as a supplement with some evidence for modest blood pressure lowering and measurable effects on clot-related biomarkers. It cannot be described as proven prevention for heart attack or stroke, and it should not be presented as a replacement for prescribed cardiovascular treatment, risk-factor control, or perioperative safety guidance. If someone is considering it for a cardiovascular goal, the key question is whether the hoped-for benefit is worth the interaction and bleeding uncertainties.⁴⁷¹²¹³